Skip to content

Regional Nerve Block for Upper Extremity Surgery in Patients With Sarcopenia

Regional Nerve Block for Upper Extremity Surgery in Patients With Sarcopenia

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07757984
Enrollment
150
Registered
2026-08-11
Start date
2026-09-01
Completion date
2028-08-31
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve Block, Sarcopenia

Brief summary

The goal of this observational study is to learn about the impact of sarcopenia (muscle loss) on the efficacy of regional nerve blocks and postoperative recovery in patients undergoing upper extremity surgery. The main questions it aims to answer are: 1. Does sarcopenia affect the onset time and success rate of peripheral nerve blocks? 2. How does sarcopenia influence postoperative pain control and opioid consumption compared to patients receiving pure general anesthesia? Participants will undergo a preoperative muscle assessment, which includes a chair stand test and a brief ultrasound of the thigh muscle. Researchers will then observe and record their nerve block onset time (if applicable), postoperative pain scores, and recovery metrics during their hospital stay up to postoperative day 2.

Interventions

OTHERsarcopenia

Patients identified with sarcopenia based on preoperative muscle assessment.

OTHERNon-sarcopenia

Patients with normal muscle mass based on preoperative muscle assessment.

PROCEDUREGeneral Anesthesia

received general anesthesia alone

PROCEDURENerve Block

general anesthesia combined with nerve block

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum

Inclusion criteria

* Age\>=50 years old * ASA I-III * Receiving upper limb surgery under general anesthesia

Exclusion criteria

* Severe cognitive impairment or inability to cooperate with pain and motor assessment * Pre-existing neuropathy of the musculocutaneous, median, radial or ulnar nerve * (for nerve block group) Contraindications to regional nerve blockade

Design outcomes

Primary

MeasureTime frame
time to first rescue analgesiaFrom the completion of surgery up to Postoperative Day 2

Secondary

MeasureTime frameDescription
Nerve block onsetFrom the completion of local anesthetic injection up to 30 minutes
Nerve block durationFrom the successful onset of sensory block to the patient's first report of pain at the surgical site, assessed up to postoperatively day 2
Intraoperative Mean Arterial Pressure (MAP) and Heart Rate (HR)During surgery (From the induction of anesthesia to the end of surgery, an average of 2 hours)Mean Arterial Pressure (MAP) measured in mmHg and Heart Rate (HR) measured in beats per minute, assessed continuously using standard non-invasive or invasive hemodynamic monitors.
Postoperative NRSFrom the end of surgery up to 48 hours postoperatively.From the end of surgery up to postoperative day 2
Total opioid consumptionFrom the end of surgery up to postoperative day 2
Incidence of Local Anesthetic Systemic Toxicity (LAST)From the initiation of nerve block up to 24 hours postoperativelyLAST is defined as the occurrence of adverse central nervous system signs (e.g., altered mental status, seizures, tinnitus) or cardiovascular signs (e.g., arrhythmias, profound hypotension, cardiac arrest) following the administration of local anesthetics. It will be assessed clinically by the attending anesthesiologist and recorded as a binary outcome (Yes/No).
Incidence of postoperative deliriumFrom the end of surgery up to postoperative day 2The incidence of postoperative delirium will be assessed using the Confusion Assessment Method (CAM). The CAM diagnostic algorithm evaluates four features: (1) acute onset and fluctuating course, (2) inattention, (3) disorganized thinking, and (4) altered level of consciousness. Delirium is considered present if features 1 and 2 are observed, along with either feature 3 or 4. The outcome will be recorded as a binary variable (Yes/No).
ICU stayFrom ICU admission up to postoperative day 2

Countries

Taiwan

Contacts

PRINCIPAL_INVESTIGATORTsai

Chang Gung Memorial Hospital

CONTACTYi Ting Chen
cheneating23@gmail.com+886 965853825

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026